Linfoma difuso de células grandes B rectal en un paciente con colitis ulcerosa

Keyphrases

• Infliximab 100%
• Immunosuppression 100%
• Ulcerative Colitis 100%
• Diffuse Large B-cell Lymphoma (DLBCL) 100%
• Young Males 50%
• Chemotherapy 50%
• Risk Factors 50%
• Inflammatory Bowel Disease 50%
• Prednisone 50%
• Doxorubicin 50%
• Male Patients 50%
• Gastrointestinal Tract 50%
• Second Dose 50%
• Rituximab 50%
• Cyclophosphamide 50%
• R-CHOP 50%
• Lymphoma 50%
• Disease Remission 50%
• Ulcerative Lesions 50%
• Large Cell 50%
• Non-Hodgkin Lymphoma 50%
• Primary Colorectal Lymphoma 50%
• Rare Forms 50%
• Presentation Form 50%

Medicine and Dentistry

• Immunosuppressive Treatment 100%
• Ulcerative Colitis 100%
• Diffuse Large B-Cell Lymphoma 100%
• Infliximab 100%
• Vincristine 50%
• Prednisone 50%
• Azathioprine 50%
• Doxorubicin 50%
• Gastrointestinal Tract 50%
• Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine 50%
• Cyclophosphamide 50%
• Rituximab 50%
• Spontaneous Remission 50%
• Inflammatory Bowel Disease 50%
• Patient with Ulcerative Colitis 50%
• Large Cell 50%
• Non-Hodgkin Lymphoma 50%
• Chemotherapy 50%